Tower Research Capital (TRC)’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3K Sell
3,612
-1,676
-32% -$5.99K ﹤0.01% 3861
2026
Q1
$18.1K Buy
5,288
+1,943
+58% +$8.54K ﹤0.01% 3546
2025
Q4
$17.2K Sell
3,345
-2,831
-46% -$17.9K ﹤0.01% 3217
2025
Q3
$50.6K Buy
6,176
+4,263
+223% +$36.3K ﹤0.01% 2522
2025
Q2
$17.4K Sell
1,913
-6,414
-77% -$60.2K ﹤0.01% 3752
2025
Q1
$80.5K Buy
8,327
+7,366
+766% +$89.4K ﹤0.01% 1891
2024
Q4
$12.7K Buy
+961
New +$11.8K ﹤0.01% 3591
2022
Q4
Sell
-1,003
Closed -$7K 5849
2022
Q3
$7K Sell
1,003
-1,484
-60% -$11.5K ﹤0.01% 4861
2022
Q2
$20K Buy
+2,487
New +$23.1K ﹤0.01% 3776

Other funds holding ALVO

Tower Research Capital (TRC)'s ALVO Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Alvotech (ALVO) stake by 32% in Q2 2026, selling an estimated $5.99K and leaving 3,612 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3861.

Tower Research Capital (TRC) first reported a position in ALVO in Q2 2022 and has held it in 9 quarters since. The position peaked at $80.5K in Q1 2025. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • Tower Research Capital (TRC) held 3,612 shares of Alvotech worth $13.3K as of Q2 2026.
  • Tower Research Capital (TRC) sold 1,676 Alvotech shares in Q2 2026, an estimated $5.99K.
  • Alvotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3861 holding.
  • Tower Research Capital (TRC) first reported a position in Alvotech in Q2 2022 and has held it in 9 quarters since.
  • Tower Research Capital (TRC)'s Alvotech position peaked at $80.5K in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.